- Lois et règlements
- eservices
-
Media Center
Hotline for Health Services for Displaced Lebanese 1787Hotline for the Patient Admission to Hospitals 01/832700COVID-19 Vaccine Registration Form covax.moph.gov.lbMoPH Hotline 1214
Are you a new member? Sign up now
close
TYSABRI - 300mg/15ml - 1 x 15ml
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L04AA23 | BioTech | Natalizumab - 300mg/15ml | 10731 | 98820/1 | TYSABRI | 300mg/15ml | 1 x 15ml | Injectable concentrated solution | Infusion | Mersaco | Biogen Netherlands BV | The Netherlands | 126,830,594 L.L | 2.44 | E2 | Biogen Netherlands BV | The Netherlands | 2/5/2024 | 0 |